Publications by authors named "Su Y Lim"

Claim this Profile
C
CliCAR: A non-genetic CAR engineering strategy to empower NK cells for targeted cancer immunotherapy.
Su Yeon Lim, Yeongbeom Kim, Seungmin Han, Hyun-Ouk Kim, Suk-Jin Ha, Kwang Suk Lim

Biomed Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma.
Fei Yang, Su Yin Lim, Ines Pires da Silva, Lijia Yu, Jordan W Conway

Cancer Cell Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reshaping Tumor-Lymph Node Immune Axis via Targeted Lymphatic Delivery of Dual-Functional Immune Modulator for Enhanced Cancer Immunotherapy.
Su Yeon Lim, Pin Liu, Ju Hwa Shin, Bum Soo Lee, Sun Ju Kim

ACS Cent Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioengineered metastatic cancer nanovaccine with a TLR7/8 agonist for needle-free intranasal immunization.
Jae Min Jung, Min Sang Lee, Young Kyu Seo, Jung Eun Lee, Su Yeon Lim

Biomaterials· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface Engineering of Natural Killer Cells with Lipid-Based Antibody Capture Platform for Targeted Chemoimmunotherapy.
Su Yeon Lim, Yeongbeom Kim, Hongbin Kim, Seungmin Han, Jina Yun, Kwang Suk Lim

Pharmaceutics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery.
Yeongbeom Kim, Jaewoo Kwak, Minyeong Lim, Su Yeon Lim, Sehyun Chae, Kwang Suk Lim

Pharmaceutics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Applications of Stereotactic Ablative Radiotherapy in Oligometastatic Colorectal Cancer.
Hasan Al-Sattar, Esele Okondo, Amir Mashia Jaafari, Inesh Sood, Jakob Hassan Dinif, Su Yin Lim

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy.
Brie-Anne Mannah, John J Park, Su Yin Lim

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function.
Heewon Park, In Kang, Susam Lee, Minsa Park, Seungcheol Kim, Su Yeon Lim

J Control Release· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanobiologically Engineered Mimicry of Extracellular Vesicles for Improved Systemic Biodistribution and Anti-Inflammatory Treatment Efficacy in Rheumatoid Arthritis.
Dahwun Kim, Hwira Baek, Su Yeon Lim, Min Sang Lee, Siyan Lyu

Adv Healthc Mater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferation.
Siwy Ling Yang, Louis DeFalco, Sainan Wang, Yi Hao Wong, Jian Han, Su Ying Lim, Jovi Jian An Lim

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates.
Su Yeon Lim, Seungmin Han, Yihyeon Kim, Hongbin Kim, Yeongbeom Kim, Kwang Suk Lim

Biomed Pharmacother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.
Yeongbeom Kim, Su Yeon Lim, Hyun-Ouk Kim, Suk-Jin Ha, Jeong-Ann Park, Kwang Suk Lim

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment.
Su Yin Lim, Suzanah C Boyd, Russell J Diefenbach, Helen Rizos

Mol Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of group I introns in generating circular RNAs as vaccines.
Kuo-Chieh Liao, Majid Eshaghi, Zebin Hong, Tzuen Yih Saw, Jian An Jovi Lim, Su Ying Lim

Nucleic Acids Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response.
Su Yin Lim, Ines Pires da Silva, Nurudeen A Adegoke, Serigne N Lo, Alexander M Menzies

Mol Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors.
Su Yin Lim, Yingxin Lin, Jenny H Lee, Bernadette Pedersen, Ashleigh Stewart

EBioMedicine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment.
Su Yeon Lim, Luna Kim, Hongbin Kim, Jeong-Ann Park, Jina Yun, Kwang Suk Lim

Pharmaceutics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in microbial and enzymatic engineering for the biodegradation of micro- and nanoplastics.
Jaewon Choi, Hongbin Kim, Yu-Rim Ahn, Minse Kim, Seona Yu, Su Yeon Lim, Kwang Suk Lim

RSC Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing in melanoma: what have we learned so far?
Su Yin Lim, Helen Rizos

EBioMedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma.
John J Park, Sabine Abou Hamad, Ashleigh Stewart, Matteo S Carlino, Su Yin Lim

Oncogenesis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.
Su Yin Lim, Laura Ferro-López, Elizabeth Barquin, Daniel Lindsay, Khin Thway

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells.
Kuo-Chieh Liao, Xuping Xie, Anna Karin Beatrice Sundstrom, Xin Ni Lim, Kiat Kee Tan, Su Ying Lim

Genome Biol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.
Zizhen Ming, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Elena Shklovskaya

J Invest Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.
Su Yin Lim, Elena Shklovskaya, Jenny H Lee, Bernadette Pedersen, Ashleigh Stewart

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis